Jeffrey Prichard
Family Medicine · Pineville, WVNPI 1508949595
Payments from drug & device makers
Across 236 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$704
- GSK$571
- AstraZeneca$502
- Lilly USA, LLC$296
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$294
- Amgen$222
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,868100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $704 |
| GSK | 37 | $571 |
| AstraZeneca | 31 | $502 |
| Lilly USA, LLC | 17 | $296 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $294 |
| Amgen | 15 | $222 |
| AbbVie | 9 | $146 |
| Abbott | 6 | $113 |
| Amarin Pharma, Inc. | 7 | $99 |
| Novartis | 5 | $98 |
| Idorsia Pharmaceuticals US Inc | 6 | $96 |
| Boehringer Ingelheim | 5 | $77 |
| Pfizer | 4 | $75 |
| Dexcom, Inc. | 4 | $70 |
| E.r. Squibb & Sons, L.L.C. | 4 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Philips North America LLC | 2 | $42 |
| Mylan Specialty L.p. | 2 | $40 |
| Esperion Therapeutics, Inc. | 3 | $39 |
| Exact Sciences | 2 | $37 |
| Genentech USA, Inc. | 2 | $31 |
| Bayer | 1 | $23 |
| Merck | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Verona Pharma, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
How this compares
$3,868 in reported general payments places this provider in the 85th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 72 | $74,388 |
| TrulicityDulaglutide | 59 | $70,987 |
| EliquisApixaban | 56 | $55,074 |
| JanuviaSitagliptin Phosphate | 48 | $45,390 |
| LinzessLinaclotide | 36 | $36,782 |
| Repatha SureclickEvolocumab | 64 | $36,165 |
| MounjaroTirzepatide | 28 | $32,712 |
| FarxigaDapagliflozin Propanediol | 34 | $31,070 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $27,437 |
| XareltoRivaroxaban | 29 | $21,421 |
| JardianceEmpagliflozin | 21 | $16,838 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $16,089 |
| RybelsusSemaglutide | 15 | $15,468 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $14,564 |
| VascepaIcosapent Ethyl | 22 | $11,860 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $296 | $103,69987 claims |
| Novo NordiskOzempic, Rybelsus | $704 | $89,85687 claims |
| PfizerEliquis, Paxlovid | $75 | $60,79080 claims |
| MerckJanuvia, Lagevrio (Eua) | $20 | $50,02261 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $502 | $48,64868 claims |
| AbbVieLinzess, Synthroid | $146 | $40,565104 claims |
| GSKTrelegy Ellipta | $571 | $27,43737 claims |
| Johnson & JohnsonXarelto | $16 | $21,42129 claims |
| Boehringer IngelheimJardiance | $77 | $16,83821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Pineville
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.